Shanghai Key Laboratory of Visual Impairment and Restoration, Department of Ophthalmology and Vision Science, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.
Int J Mol Sci. 2023 Jan 11;24(2):1447. doi: 10.3390/ijms24021447.
Diabetic retinopathy (DR), the most common microvascular compilation of diabetes, is the leading cause of vision loss and blindness worldwide. Recent studies indicate that retinal neuron impairment occurs before any noticeable vascular changes in DR, and retinal ganglion cell (RGC) degeneration is one of the earliest signs. Axons of RGCs have little capacity to regenerate after injury, clinically leading the visual functional defects to become irreversible. In the past two decades, tremendous progress has been achieved to enable RGC axon regeneration in animal models of optic nerve injury, which holds promise for neural repair and visual restoration in DR. This review summarizes these advances and discusses the potential and challenges for developing optic nerve regeneration strategies treating DR.
糖尿病性视网膜病变(DR)是糖尿病最常见的微血管并发症,是全球视力丧失和失明的主要原因。最近的研究表明,在 DR 出现任何明显的血管变化之前,视网膜神经元损伤就已经发生,而视网膜神经节细胞(RGC)变性是最早的迹象之一。RGC 的轴突在损伤后几乎没有再生能力,这导致临床上视觉功能缺陷变得不可逆转。在过去的二十年中,在视神经损伤的动物模型中实现了 RGC 轴突再生的巨大进展,这为 DR 的神经修复和视觉恢复带来了希望。本综述总结了这些进展,并讨论了开发治疗 DR 的视神经再生策略的潜力和挑战。